The expression of a gene requires not only a normal coding sequence but also intact regulatory regions, which can be located at large distances from the target genes, as demonstrated for an increasing number of developmental genes. In previous mutation studies of the role of FOXL2 in blepharophimosis syndrome (BPES), we identified intragenic mutations in 70% of our patients. Three translocation breakpoints upstream of FOXL2 in patients with BPES suggested a position effect. Here, we identified novel microdeletions outside of FOXL2 in cases of sporadic and familial BPES. Specifically, four rearrangements, with an overlap of 126 kb, are located 230 kb upstream of FOXL2, telomeric to the reported translocation breakpoints. Moreover, the shortest region of deletion overlap (SRO) contains several conserved nongenic sequences (CNGs) harboring putative transcription-factor binding sites and representing potential long-range cis-regulatory elements. Interestingly, the human region orthologous to the 12-kb sequence deleted in the polled intersex syndrome in goat, which is an animal model for BPES, is contained in this SRO, providing evidence of human-goat conservation of FOXL2 expression and of the mutational mechanism. Surprisingly, in a fifth family with BPES, one rearrangement was found downstream of FOXL2. In addition, we report nine novel rearrangements encompassing FOXL2 that range from partial gene deletions to submicroscopic deletions. Overall, genomic rearrangements encompassing or outside of FOXL2 account for 16% of all molecular defects found in our families with BPES. In summary, this is the first report of extragenic deletions in BPES, providing further evidence of potential long-range cis-regulatory elements regulating FOXL2 expression. It contributes to the enlarging group of developmental diseases caused by defective distant regulation of gene expression. Finally, we demonstrate that CNGs are candidate regions for genomic rearrangements in developmental genes.
Introduction
The expression pattern of many developmental genes is regulated at different levels. Usually, basal gene expression is controlled by the core promoter, located imme-diately upstream of the ORF. However, spatiotemporally and quantitatively correct gene expression is often controlled by long-range cis-acting regulatory elements as distant as 1.1 Mb (Velagaleti et al. 2005) . These elements (enhancers, insulators, and locus-control regions) can be located upstream or downstream of the transcription unit of a gene. Interspecies comparative studies show a strong evolutionary conservation of these elements, which may reside in unrelated neighboring genes or intergenic regions. Genomic rearrangements involving such elements outside of a transcription unit can give rise to human disease by a dissociation of the transcrip-tion unit and its cis-acting regulatory elements, by an alteration of the chromatin structure, or by both mechanisms (reviewed by Kleinjan and van Heyningen [2005] ).
Recently, it was shown that heterozygous mutations of the FOXL2 gene (MIM 605597), which encodes a forkhead transcription factor, cause both types of blepharophimosis-ptosis-epicanthus inversus syndrome (BPES [MIM 110100]) . BPES is a rare, autosomal dominant developmental disorder characterized by an eyelid malformation. Two subtypes have been identified; type I is associated with premature ovarian failure (POF), whereas type II is not (Zlotogora et al. 1983) . It was shown that haploinsufficiency of FOXL2 was caused by intragenic mutations, in most cases, and by submicroscopic deletions encompassing FOXL2 and neighboring genes, in two cases (De Baere et al. 2001 . A genotype-phenotype correlation was proposed mainly on the basis of intragenic mutations distinguishing the two BPES types at the molecular level . Despite the ovarian phenotype in BPES, several studies have indicated that mutations in FOXL2 do not play a major role in causing idiopathic POF (De Baere et al. 2001 Harris et al. 2002; Bodega et al. 2004) .
A spatiotemporally restricted expression pattern of the FOXL2 transcript and protein was demonstrated in several species (human, mouse, and goat). It was shown to be expressed in developing eyelids and in granulosa cells of fetal and adult ovaries (Crisponi et al. 2001; Cocquet et al. 2002 Cocquet et al. , 2003 . Recently, two studies presenting homozygous knockout mice showed that granulosa cell function is crucial not only for oocyte growth but also for ovarian maintenance, thus providing a molecular mechanism for POF in BPES in vivo (Schmidt et al. 2004; Uda et al. 2004) .
During the positional cloning of FOXL2, three balanced translocations were characterized in patients with a classic BPES phenotype. It was shown that the breakpoints of these translocations disrupt two other genes (BPESC1 and MRPS22), both devoid of pathogenic mutations in other patients with BPES, suggesting a position effect (De Baere et al. 2000; Praphanphoj et al. 2000; Crisponi et al. 2001 Crisponi et al. , 2004 .
Sequencing of the FOXL2 ORF, in combination with FISH analysis with a probe encompassing the FOXL2 gene, revealed mutations in !70% of patients with BPES (De Baere et al. 2001 . Here, we applied a novel mutation-detection strategy consisting of multiplex ligation-dependent probe amplification (MLPA), genotyping with 160 microsatellites and SNPs, and comprehensive FISH analysis. This approach led to the identification of nine novel deletions encompassing FOXL2, which ranged from partial and total gene deletions to microdeletions and submicroscopic deletions. Notably, five novel deletions were found either upstream or downstream of the transcription unit of FOXL2. These genic and extragenic (micro)deletions account for 11% and 5%, respectively, of all molecular defects found in our cohort with BPES. Finally, we report the first case of germline mosaicism in a family with BPES that is confirmed at the molecular level.
Material and Methods

Patients and Diagnostic Criteria
The 37 consenting probands with BPES who were included in this study presented with blepharophimosis, ptosis, epicanthus inversus, and telecanthus. The clinical diagnosis was given by a clinical geneticist or an ophthalmologist. When possible, karyotyping was performed in the referring laboratory. The karyotype was not confirmed by us. In each proband, intragenic mutations were excluded by sequencing of the FOXL2 ORF, as described by De Baere et al. (2001) .
Custom-Made MLPA
MLPA permits relative quantification of changes in copy number of specific chromosomal sequences (Schouten et al. 2002) . A custom-made deletion-detection kit for FOXL2 was developed by MRC-Holland (P054 FOXL2) and contains three different probes for FOXL2 (FOXL2-D01, FOXL2-D02, and FOXL2-D03), four probes for the ATR gene (located at 3q22-24), and probes for other genes (TWIST, FOXC1, PITX2, FOXC2, and OA1) . Probe FOXL2-D01 is located in the forkhead domain (c.252-351; g.489-588) , probe FOXL2-D02 is between the forkhead domain and the polyalanine tract (c.575-641; g.812-878) , and probe FOXL2-D03 is downstream of the polyalanine tract (c.1053-1113; g.1290-1350) . MLPA was performed in accordance with the manufacturer's instructions.
FISH
A genomic BAC contig of region 3q23 was obtained from the National Center for Biotechnology Information (NCBI) database. BACs were obtained from The Wellcome Trust Sanger Institute and BACPAC Resources Center. PACs and cosmids had been previously obtained from the UK-Medical Research Council and were mapped by FISH (De Baere et al. 1999) . BAC, PAC, and cosmid DNA was prepared and labeled with the use of standard conditions. FISH analysis was performed as described by De Baere et al. (1999) .
Microsatellite Analysis
Fifteen polymorphic microsatellites (with prefix "D3S") were selected from the NCBI on the basis of location and heterozygosity. Primer sequences of markers with prefixes "VY" and "NU" were obtained from Udar et al. (2003) . A third series of microsatellites (Tel2 and markers with prefix "EDB") was developed by a manual search for repeats in the BAC sequences derived from NCBI. For a fourth series (with prefix "DB"), the different BAC sequences were analyzed using the Find Simple Repeats software, which selects repetitive sequences that are expected to have a very high degree of polymorphism. The search was confined to sequences presenting repetitions with a maximum of 4 nt and having a total length of at least 12 nt. Sequences with a score у30 were selected for primer design. Primer sequences are given in table 1. Characterization of the polymorphic nature of the known and novel microsatellites was performed in a white population by use of an M13-system described by Schuelke (2000) . For allele sizing, aliquots of PCR reaction were mixed with ROX-500 or ROX-1000 size standard (Applied Biosystems) and formamide and were separated on an ABI PRISM 3100 Genetic Analyzer (Applied Biosystems). Fragment sizing was performed automatically using GeneScan version 3.7. The different microsatellite alleles were numbered consecutively, in order of increasing size. The numbering is different for each family.
SNaPshot Analysis
Twenty-seven SNP loci were selected from the International HapMap Project database, and amplification primers were designed so that PCR products of ∼300 bp were obtained. Typing primers were designed to anneal to the target DNA flanking the 3 end of the SNP. A standard PCR reaction was performed, followed by exonuclease I and shrimp alkaline phosphatase (SAP) treatment (Amersham). A single-nucleotide primer extension reaction was performed using an ABI PRISM SNaPshot Multiplex kit (Applied Biosystems), in accordance with the manufacturer's instructions. After SAP treatment, products were separated on an ABI PRISM 3100 Genetic Analyzer (Applied Biosystems) and were analyzed with GeneScan version 3.7. Numbers were assigned to alleles as follows: A p 1, C p 2, G p 3, and Tp 4.
To assess the degree of germline mosaicism in an unaffected male, quantitative SNaPshot analysis was performed as described by Má tyá s et al. (2002) . For normalization, genomic samples from four unrelated individuals who have an identical SNP haplotype as that of the test sample were used as controls.
Long-Range PCR
For long-range PCR, the Expand Long Template PCR System (Roche) was used. A master mix of 50 ml contained 300 ng of genomic DNA, 0.5 mM of each primer, 5 ml of Expand Long Template PCR buffer 3 (containing 10 # PCR buffer and 27.5 mM MgCl 2 ), 3.75 U of Expand Long Template enzyme mix (containing Taq DNA polymerase and Tgo DNA polymerase), 500 mM of each dNTP, and 3 mM additional MgCl 2 . Cycling conditions included an initial denaturation cycle at 94ЊC for 2 min, followed by 10 cycles at 94ЊC for 20 s, 65ЊC for 30 s, and 68ЊC for 12 min; 25 cycles at 94ЊC for 30 s and 65ЊC for 30 s and elongation for 12 min plus 20 s for each successive cycle; and a final extension at 72ЊC for 7 min.
Construction of a High-Resolution Physical Map Covering Microdeletions
First, we generated a sequence contig of 16 overlapping RPCI-11 BAC clones that span ∼1.8 Mb surrounding FOXL2 by a search of GenBank (NCBI). The polymorphic microsatellites selected from NCBI were positioned on this BAC contig by use of the reference numbering of build 34, version 3 ("the golden path"), and by use of BLAST (NCBI). The localization of the anonymous microsatellites and SNPs was verified by BLAST searches against the BAC sequences. The exact PAC and cosmid localization was determined by BLAST after PAC and cosmid end sequencing, in accordance with standard protocol. Finally, the different known and unassigned genes that are located in this region were added to the map according to NCBI data.
Comparative Sequence Analysis
To identify conserved nongenic sequences (CNGs), comparative sequence analysis of the regions of interest was performed using the University of California-Santa Cruz (UCSC) Genome Browser. The UCSC Multiz Alignments and Conservation track contains a measure of evolutionary conservation in human, chimp, mouse, rat, dog, chicken, pufferfish, and zebrafish based on a phylogenetic hidden Markov model (phastCons). The overall conservation score across all species, as well as pairwise alignments of each species aligned to the human genome, were retrieved, and gapped alignments were included. The length of the alignment is based on the lengths of gaps in the human sequence at those alignment positions, relative to the longest nonhuman sequence. A, Physical map of a 1.8-Mb region flanking FOXL2 that shows the position of the BACs, PACs, cosmids, microsatellites, and SNPs that were used for identification and delineation of the deletions. The map is drawn to scale; the size equivalent to 50 kb is given at the bottom left corner. The location of FOXL2 is indicated by a vertical black line. The top line represents the localization of SNPs, and the second line contains the known and anonymous microsatellites used in this study. In the third line, the location of the genes in this region is shown, whereas the BACs, PACs, and cosmids used for FISH are shown below the line. The lower part of A is an overview of all deletions identified in this study, except one. Every line represents a patient or family in whom a deletion was found. The dashed red line shows the maximal extent of the deletion. The first 10 lines represent the deletions that encompass FOXL2. The deletion identified in BPES11 is not shown, since the extent of the deletion could not be determined because of a lack of material for FISH and microsatellite analysis. The second group represents the five extragenic deletions (four upstream and one downstream). Clinical details and molecular data on the patients with deletions are shown in table 2. In a box at the bottom right, a detailed view of the SRO of the four upstream extragenic deletions is shown. The position of FOXL2 is marked by a vertical dashed black line, and the SRO is shown by the dashed red line. The positions of the known three translocation breakpoints at 3q23 in BPES and of the orthologue of the PIS locus are indicated by vertical arrows. B and C, UCSC Genome Browser map of the SRO of the four upstream extragenic rearrangements in families BPES12, BPES13, BPES14, and BPES15. CNGs are highlighted at the bottom with red boxes. Their names, based on our arbitrary numbering, are given below the boxes. Details on all CNGs can be found in table 4. The CNGs shown in B are evolutionarily conserved up to chicken. C represents a more detailed view of CNG3-CNG7. CNG3-CNG5 are conserved up to zebrafish and/or pufferfish. They all represent potential cis-regulatory elements of the FOXL2 region. D, UCSC Genome Browser map of the sequence contained in the downstream extragenic rearrangement in family BPES16. Five CNGs are indicated in this 3 SRO, of which several are conserved up to zebrafish and/or pufferfish (CNG14, CNG18, and CNG22-CNG24).
November 2003 (danRer1). Our selection criteria included conservation at least up to chicken, pufferfish, and/or zebrafish, independent of alignment length, percentage of conservation, and presence of gaps.
The respective sequences of the selected elements and their corresponding mouse sequences were retrieved through the UCSC Genome Browser. Apart from these sequences, an available 48-kb goat sequence from the polled intersex syndrome (PIS) locus (GenBank accession number AF404302) was retrieved for human-goat comparison with the use of mVista. A pairwise alignment was performed between human and mouse, human and goat, human and chicken, human and pufferfish, and human and zebrafish by use of ClustalW. To exclude the coding potential of all putative CNGs, the human sequence of the conserved region was compared with all available EST and protein sequences in GenBank, as well as with all gene predictions for the selected region available from the UCSC Genome Browser and the Biomax Human Genome Database (blastn, blastx, tblastx, and nrprot). In addition, sequences were scanned for repetitive elements using RepeatMasker. Sequences that did not show significant similarity to known proteins, genes and/or transcripts, or transposable elements were selected as CNGs. These were searched against the Transfac database (version 8.3) of known vertebrate cis-acting regulatory DNA elements and trans-acting factors by use of the Match tool included in that database (Matys et al. 2003) . Only highly significant matches with transcription-factor binding sites were considered, by use of the built-in "minimize false positive matches" setting.
Results and Discussion
The mutation detection rate of !70% in previous mutation studies of FOXL2 in BPES could be explained by clinical misdiagnosis; the sensitivity of the strategy used, which might not allow detection of changes in gene copy number or in distant sequences outside of the transcription unit of FOXL2 (De Baere et al. 2001 ; or the presence of a second BPES locus, although there is no evidence to support the existence of a second locus. Here, we developed a novel combined approach consisting of (1) custom-made MLPA for detection of changes in gene copy number of FOXL2 and other genes; (2) a genotyping panel, comprising 15 known and 32 anonymous microsatellites and 26 SNPs; and (3) comprehensive FISH analysis whenever possible.
Genomic Rearrangements Encompassing FOXL2
A clue to subtle FOXL2 deletions was found in similar observations for FOXC1, which encodes a forkhead transcription factor associated with ocular anterior segment dysgenesis (IRID1 [MIM 601631]). Irrespective of whether the gene is duplicated or deleted, a nearly identical ocular phenotype is observed, showing that exact gene dosage of FOXC1 is critical for normal eye development (Lehmann et al. 2003) .
Our approach allowed identification of 11 deletions encompassing FOXL2, of which 9 are novel. These deletions contribute to 11% (11/100) of all molecular defects found in our series of patients with BPES and are found in 30% (11/37) of mutation-negative patients. They occur in sporadic cases and familial cases and are absent in all unaffected family members analyzed. A graphical overview of these deletions is given in figure  1A . Clinical data for the 11 families and molecular details on the deletions are summarized in table 2.
The rearrangements include one partial FOXL2 deletion (in BPES10), an 8-kb deletion removing the whole FOXL2 ORF (in BPES9), two microdeletions of up to 420 kb, encompassing FOXL2 and neighboring genes (in BPES7 and BPES8), four submicroscopic deletions (in BPES2, BPES4, BPES5, and BPES6), and two micro- 
Figure 2
Pedigrees with BPES and a rearrangement encompassing FOXL2 or located outside of the transcription unit. Intragenic FOXL2 mutations were excluded by sequencing of the ORF in all patients. MLPA was performed to assess changes in gene copy number, and haplotypes are based on microsatellite or SNP analysis. An exclamation mark (!) indicates hemizygosity of an allele. BPES9, Microsatellite analysis in two generations of this French family showed apparent linkage to FOXL2. However, no intragenic FOXL2 mutation was found in affected members. MLPA analysis revealed a total gene deletion of FOXL2. Long-range PCR revealed the breakpoints of an 8-kb deletion ( fig. 3 ). The occurrence of secondary amenorrhea in II:1 suggests this family has type I BPES. In addition, III:2 has a heart malformation in association with BPES. BPES16, In this family, two affected half-sisters (II:1 and II:3) have BPES, whereas their father (I:2) is clinically unaffected, suggesting germline mosaicism. FISH and microsatellite analysis revealed an extragenic deletion of 188 kb located 3 of FOXL2 in the half-sisters. Microsatellite analysis showed an apparent absence of this deletion in their father. However, quantitative studies revealed somatic mosaicism for this deletion in 5% of DNA from his leucocytes and 10% of DNA from his sperm cells, confirming germline mosaicism at the molecular level (table 3) . BPES12, Upstream microdeletion in a 14-year-old male with sporadic BPES and additional features. MLPA showed normal FOXL2 and ATR gene copy numbers, whereas several microsatellites at a distance from FOXL2 were hemizygous, indicating a deletion outside of the transcription unit. The centromeric breakpoint of the deletion is located in a 69-kb interval between microsatellites EDB14 and DB17; at the telomeric side, the deletion extends beyond the borders of the physical map in figure 1A , but does not contain D3S1309. The deletion encompasses at least several known and unknown genes (LOC389152, BPESC1, MRPS22, COPB2, RBP2, ACTGP1, RBP1, NMNAT3, and CLSTN2) and extends beyond 1.9 Mb. The contribution of each gene to the psychomotor retardation and other associated features in this patient is unclear. BPES13, Upstream microdeletion of maternal origin in a 2-year-old female with sporadic BPES who had normal psychomotor development and microcephaly. The deletion spans 567 kb at the most; the centromeric breakpoint is located between microsatellites EDB14 and DB16, and the telomeric breakpoint is between markers DB19 and D3S2435. The deletion covers part of BPESC1, MRPS22, COPB2, RBP2, ACTGP1, RBP1, and NMNAT3. BPES14, Microdeletion of ∼200 kb 5 of FOXL2 in two affected females, I:2 and II:1, of a two-generation family with type II BPES. FISH analysis with probes RP11-548O1, RP11-306L14, RP11-319G6, Pac204O7, and Cos11L10 showed normal hybridization signals on both chromosomes 3, whereas RP11-657M13, Cos12P5, and Pac208L5 were deleted. One normal and one lighter signal were seen with RP11-219D15 and PAC169C10, confirming that the deletion breakpoints are located in these probes. The centromeric breakpoint of the deletion is located between DB16 and D3S3586, and the telomeric breakpoint is between EDB2 and DB5. BPES15, Extragenic microdeletion found in a five-generation Belgian family with BPES type II, previously linked to 3q23 (Messiaen et al. 1996) . This 126-kb microdeletion is the smallest one upstream of FOXL2 and delineates the SRO of the different microdeletions located at this side of FOXL2 (detailed view in fig. 1A ). FISH probes RP11-657M13 and PAC208L5 showed one lighter and one normal hybridization signal, thus indicating the borders of the deletion. Analysis with adjacent probes showed two normal signals. The hemizygous microsatellites indicate that the centromeric breakpoint is located between rs10935309 and rs955084 and the telomeric breakpoint is between rs6802174 and rs4894405 ( fig. 1A ). scopic deletions (in BPES1 and BPES3) ( fig. 1A and table  2) . In patient BPES11, MLPA analysis revealed a total FOXL2 deletion; however, the extent could not be determined because of the lack of appropriate patient and parental material. The deletion breakpoints are scattered, suggesting lack of a deletion-prone region and nonhomologous end joining as the common causal mechanism (Shaw and Lupski 2004) , which is supported by characterization of the junction fragment of an 8-kb deletion in family BPES9 with BPES type I ( fig. 2 and  fig. 3C and 3D ). Attempts to characterize the junction fragments by long-range PCR failed for the other subtle deletions presented in this study.
In the three families with BPES in which several affected members are heterozygous for a total gene deletion (BPES9), a microdeletion (BPES7), or a submicroscopic deletion (BPES5), microsatellite analysis showed similar extents of the deletion in the affected family members of different generations, suggesting stability during meiosis ( fig. 2 and fig. 4 ).
Previously, two submicroscopic deletions of 13.8 Mb and 3.2 Mb were found in patient BPES2 and the proband of BPES5, respectively, both of whom had psychomotor retardation and microcephaly as associated features. These findings led to a preliminary genotypephenotype correlation (De Baere et al. 2001 . Here, we identified a submicroscopic deletion of 13.5 Mb in a young woman with sporadic BPES (BPES4) who has microcephaly but apparently normal psychomotor development, suggesting that the extent of the deletion is not necessarily in linear correlation with the occurrence of developmental delay (table 2 and fig. 1A ). In a recent study, it was postulated that mental retardation is associated with a heterozygous deletion of the Seckelassociated ATR gene located 3.6 Mb telomeric to FOXL2 (Gille et al. 2003 ). In our series of patients, however, there was no consistent correlation between ATR haploinsufficiency and developmental delay, as seen in patient BPES4 and family BPES5 (table 2) .
In addition, in 9 of 11 patients, the BPES type could not be determined (for prepubertal females or males with sporadic BPES). However, in the two families for which it was possible to assess the BPES type (BPES9 and BPES11), the deletion was found to lead to BPES and POF (type I), which is in agreement with previous genotype-phenotype correlations between heterozygous in-
Figure 4
Haplotypes of families BPES5 and BPES7, in which affected members carry a deletion encompassing FOXL2, illustrating the stability of deletions in the different generations. The legend is available in its entirety in the online edition of The American Journal of Human Genetics. Table 3 Results of Quantitative SNaPshot Analysis with SNPs rs6773514, rs9289566, and rs9879784
The table is available in its entirety in the online edition of The American Journal of Human Genetics.
tragenic mutations leading to a FOXL2 null allele and BPES type I . Because of the small sample size, this hypothesis needs to be evaluated in additional studies of patients carrying (micro)deletions.
To allow reliable genotype-phenotype correlations for psychomotor development and POF risk, an accurate delineation of deletions is a prerequisite. In some informative families, it was possible to determine the parental origin of the deletion, but no parent-of-origin effect was observed (maternal:paternal deletion ratio was 4:3) (table 2). Thus, BPES does not belong to the group of conditions in which sex-dependent mechanisms may play a role in the origin of the underlying genomic rearrangement (e.g., Charcot-Marie Tooth 1A and hereditary neuropathy with liability to pressure palsies) (Lopes et al. 1997) .
Genomic Rearrangements Outside of the Transcription Unit of FOXL2
A complex regulation of gene expression has been suggested for several forkhead transcription factors by the occurrence of chromosomal rearrangements (translocations) upstream (FOXC1) and downstream (FOXC2) of their respective transcription units (Davies et al. 1999; Fang et al. 2000) . For the FOXL2 locus, specifically, three translocation breakpoints located 170 kb upstream of the disease gene cause exactly the same phenotype as loss-of-function mutations (De Baere et al. 2000; Praphanphoj et al. 2000; Crisponi et al. 2001 Crisponi et al. , 2004 .
Here, we report five novel deletions mapping upstream and downstream of the transcription unit of FOXL2 in patients with BPES with a phenotype identical to that caused by intragenic mutations. The presence of an intact transcription unit (coding sequence and copy number) was confirmed by sequencing and MLPA in all affected patients. The extragenic genomic rearrangements contribute to 5% (5/100) of all the molecular defects identified in our series of patients with BPES and are found in 14% (5/37) of our mutation-negative patients with BPES. They are found in patients with sporadic BPES and patients with familial BPES and are absent in unaffected individuals. An overview of the location and extent of these rearrangements is given in figure 1A , and relevant clinical data for the patients are given in table 2.
First, we identified a genomic rearrangement-presumed to be a microdeletion of ∼188 kb-downstream of FOXL2 in family BPES16, in which two affected halfsisters have typical BPES, whereas their father is clinically unaffected, which is suggestive of germline mosaicism ( fig. 2 and table 2) . To confirm paternal germline mosaicism at a molecular level, quantitative SNaPshot analysis was performed for three informative SNPs located in the deletion (rs9879784, rs9289566, and rs6773514) (table 3). We estimated that ∼10% of the paternal germ cells and 5% of somatic peripheral blood lymphocytes carry the deletion (table 3) . The estimated recurrence risk in this family is 10%, being significantly higher than the risk of a de novo event (!1%). This is the first case of germline mosaicism in BPES that is documented at the molecular level. This study indicates that this is an important issue to be considered in genetic counseling.
Second, we identified four overlapping microdeletions, which ranged from 126 kb to 1.9 Mb, upstream of the transcription unit of FOXL2. These extragenic deletions were found in two patients with a sporadic form of BPES (BPES12 and BPES13) and in two families (BPES14 and BPES15) ( fig. 1A and fig. 2 ). In two of these families, assessment of the BPES type was possible; the absence of female infertility or overt POF in affected females of families BPES14 and BPES15 suggests that these 5 -located microdeletions do not significantly perturb ovarian expression of FOXL2 and thus lead to BPES type II.
Of the two affected half-sisters in family BPES16 with the downstream microdeletion, II:3 has typical BPES with apparently normal psychomotor development at age 4 years, whereas II:1 has BPES and also presents moderate learning difficulties that were apparent from age 6 years, intrauterine and postnatal growth retardation, and microcephaly ( fig. 2 and table 2 ). She was born at a gestational age of 32 weeks because of preeclampsia. There is no indication of a different extent of the deletion in the two patients. Another patient (BPES12), heterozygous for a 1.9-Mb upstream deletion, has BPES and presents additional features, including microcephaly, intrauterine and postnatal growth retardation, and a ventricular septum defect ( fig. 2 and table  2 ). These additional features might represent a contiguous gene syndrome that can be explained by the extent of the deletion. In the other three families (BPES13, BPES14, and BPES15), no associated features were present. For the extragenic rearrangements, we can conclude that there is no association with psychomotor retardation and that there are as yet no arguments for a correlation with POF risk.
In familial cases BPES14, BPES15, and BPES16, microsatellite and FISH analysis indicated that the extent of the respective extragenic deletion is equal in each generation, suggesting stability during meiosis in these families ( fig. 2) . These clinical and molecular observations underscore the value of using complementary tools to delineate the extent of microdeletions together with assessment of the gene copy number of FOXL2.
The shortest region of deletion overlap (SRO) of the 5 microdeletions involves a 126-kb region. Interestingly, it contains the human orthologue of the PIS locus in the goat. PIS, characterized by polledness (absence of horns) and XX intersexuality, is an animal model for BPES. Pailhoux et al. (2001) showed that it was caused by a 12-kb deletion located 280 kb upstream of FOXL2. This deletion does not contain any coding sequences and affects transcription of at least two genes in the PIS goat: the noncoding PISRT1 and FOXL2, located at 20 kb and 280 kb from the deletion, respectively. It was suggested that the PIS locus contains elements involved in long-range cis-regulation of goat FOXL2 (Pailhoux et al. 2001) . Our current study lends further support to this hypothesis.
Moreover, this SRO is located telomeric to three known translocation breakpoints in BPES ( fig. 1A) . Crisponi et al. (2004) noted that these breakpoints are all located in intron 6 of the MRPS22 gene. Using humanmouse comparative sequence analysis, they showed the presence of three highly conserved sequence blocks upstream of the most distal breakpoint, in introns 6, 11, and 12 of MRPS22. The PIS locus was shown to be located in the conserved sequence block in intron 11 of MRPS22. It was postulated that these conserved sequence blocks are candidate regions that might function as distant enhancers or have an influence on higher-order chromatin structure, both of which affect long-range cisregulation of FOXL2 expression.
CNGs in the SRO of Extragenic Rearrangements
Recent experimental approaches demonstrated that a fraction of CNGs in the genome act as cis-transcriptional regulators, although little is known about their function (Dermitzakis et al. 2002 (Dermitzakis et al. , 2003 . Furthermore, it has been shown that conserved sequences are clustered around developmental genes and function as regulatory elements that affect embryonic development (Bejerano et al. 2004; Plessy et al. 2005 ). In addition, genomic variation in CNGs is presumed to be associated with phenotypic variability and even with human monogenic conditions (reviewed by Dermitzakis et al. [2005] ). To identify potential CNGs, a comparative sequence analysis was undertaken in the SRO of the extragenic deletions. We made use of publicly available, gapped and ungapped alignments of the UCSC Genome Browser. Although a human-mouse alignment is generally used, we made a selection of conserved sequences across more distant species to enhance the functional significance of the selected CNGs. We performed human-chicken, human-pufferfish, human-zebrafish, and human-goat comparisons (the latter only for an available 48-kb goat sequence [GenBank accession number AF404302]). In the two regions of interest, we identified 25 putative CNGs common to human and chicken, pufferfish, and/or zebrafish and 1 common to human and goat. Seventeen of those were eventually selected as CNGs, after we filtered for coding and transposable elements (table 4). Some of them (CNG3-CNG5) are conserved up to pufferfish or zebrafish, strongly suggesting that they function as a regulatory element (table 4) . CNG3-CNG7 are all contained in the human orthologue of the PIS locus. These CNGs were found to be located in the 9-kb conserved sequence block previously described by Crisponi et al. (2004) .
Analysis of these sequences with a Transfac database revealed several interesting putative transcription-factor binding sites for FOXP3 in CNG5 and CNG9; for HNF-1 in CNG3, CNG9, CNG22, and CNG24; for HNF-4 in CNG1 and CNG2; and for embryonic gonadal regulator SOX9 in CNG3. Interestingly, a regulatory link between SOX9 and the PIS locus has already been suggested by Nikic and Vaiman (2004) . We found that a binding site for FOXL1 (ATTCAATAAAGAAGTA), previously identified by Crisponi et al. (2004) in the 9-kb conserved sequence block, was situated in CNG3. The conserved nature of the elements located in the human orthologue of the PIS locus, together with the prediction of potentially relevant binding sites, provide arguments that they are cis-acting elements (e.g., an enhancer) regulating correct spatiotemporal FOXL2 expression during embryonic development.
It is nearly impossible to obtain human samples that would allow meaningful analysis of regulation of FOXL2 expression in developing eyelids and ovary. Such analysis currently relies on genotype-phenotype correlations of genomic rearrangements and BPES, comparative sequence analysis, and experimental validationfor instance, in animal models. In the two families in which the BPES type could be assessed, BPES14 and BPES15, we found that the 5 extragenic rearrangements led to BPES type II. This "mild" phenotype can be explained either (1) by a selective regulation of craniofacial FOXL2 expression by the 5 distant elements or (2) by regulation of both craniofacial and ovarian expression but with the absence of an ovarian phenotype in the case of a heterozygous deletion. The latter situation would be identical to the regulation of FOXL2 expression in the goat, in which both the craniofacial and ovarian expression appear to be regulated by the PIS locus, but in which phenotypic expression of polledness and XX intersexuality depend on the heterozygous and homozygous states of the deletion, respectively.
There are other diseases known to be caused by genomic rearrangements lying at considerable distances from the disease gene and leading to phenotypes identical to those resulting from intragenic mutations. However, the majority is caused by chromosomal rearrangements (translocations), and only a minority results from deletions presumably affecting a regulatory element. The first reported example was that of the locus of control region (LCR) of the b-globin gene cluster. Translocation breakpoints and deletions in this conserved element cause autosomal recessive b-thalassemia due to silencing of the b-globin gene, which maps 50 kb downstream of the LCR (Driscoll et al. 1989) . A hotspot for microdeletions has been identified, in patients with X-linked deafness type 3, that is 900 kb proximal to the POU3F4 disease gene. The 8-kb SRO of these deletions contains a 2-kb sequence that is 80% conserved between human and mouse (de Kok et al. 1996) . More recently, the autosomal recessive van Buchem disease was found to be caused by a homozygous deletion that is 52 kb downstream of the disease gene SOST and contains two CNGs (Balemans et al. 2002) . Similarly, the upstream and downstream genomic rearrangements described here dissociate putative regulatory CNGs from their target gene FOXL2 and lead to BPES, one of the first autosomal dominant conditions for which this mechanism has been demonstrated.
Our approach led to the identification of a molecular defect in 16 (43%) of 37 mutation-negative patients with BPES analyzed in this study. The lack of a sequence variation or a rearrangement in 21 patients, representing 17% (21/121) of the total patient group, might be explained by the fact that assessment of the four diagnostic criteria of BPES was done by different clinicians. In addition, the current strategy does not allow for detection of inversions and subtle extragenic rearrangements, such as deletions, duplications, and point mutations in regulatory elements. The latter mutational mechanism was demonstrated in autosomal dominant preaxial polydactyly syndrome in humans, for which four different pathogenic point mutations were found in a regulatory element of 750 bp named "ZRS," apparently regulating expression of SHH that maps 1 Mb away (Lettice et al. 2003) .
General Conclusions
In summary, this is the first study, to our knowledge, to show that deletions mapping downstream and upstream of the FOXL2 transcription unit cause BPES. Several potential upstream and downstream cis-acting regulatory elements were identified by delineation of these genomic rearrangements and by comparative genomics. The identification of the upstream deletions containing the human orthologue of the PIS locus in four patients with BPES provides evidence of human-goat conservation of the regulation of FOXL2 expression and of the mutational mechanism. This study provides insight into the regulation of expression of FOXL2, one of the earliest markers of ovarian development. More generally, it contributes to the enlarging group of human developmental diseases caused by defective long-range regulation of gene expression. It further demonstrates one of the functions of conserved noncoding regionsthat is, to act as a cis-regulatory element. Finally, our results emphasize that CNGs may be candidate regions for harboring genomic rearrangements in monogenic developmental disorders.
